Select Publications

Akerley WL et al. Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer. Proc ASCO 2008;Abstract 8043.

Genentech Press Release. Update on “AVAiL” phase III study of Avastin plus chemotherapy in first-line, advanced, non-squamous, non-small cell lung cancer. Genentech, April 2008. Available at: www.gene.com/gene/news/press-releases/display.do?method=detail&id =11207.

Manegold C et al. Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with
advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704. Proc ASCO 2007;Abstract LBA7514.

Sandler AB et al. Retrospective study of clinical and radiographic risk factors associated with early onset, severe pulmonary hemorrhage in bevacizumab-treated patients with advanced non-small cell lung cancer (NSCLC). Proc ASCO 2008;Abstract 8074.

Sandler A et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355(24):2542-50. Abstract

Zinner R et al. Compassionate use experience with gefitinib in poor performance (PS) patients with advanced non-small-cell lung cancer (NSCLC) treated in an expanded access program (EAP). Proc ASCO 2004;Abstract 7082.

Home

EDITOR
Neil Love, MD

INTERVIEWS

Thomas J Lynch, MD
- Select publications

F Anthony Greco, MD
- Select publications

Robert Pirker, MD
- Select publications

Lung Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures

Editor's Office